7/30/14

Plasma exchange



Indications
Plasma exchange may be used to remove circulating toxins or to replace missing plasma factors. It may be used in sepsis (e.g. meningococcaemia). In patients with immune mediated disease (e.g. Guillain–Barre syndrome, thrombotic thrombocytopaenic purpura), plasma exchange is usually a temporary measure while systemic immunosuppression takes effect. Most diseases require a daily 3–4L plasma exchange repeated for at least four
further occasions over 5–10 days.

Techniques
Cell separation by centrifugation 
Blood is separated into components in a centrifuge. Plasma (or other specific blood components) is discarded and a plasma replacement fluid is infused in equal volume. Centrifugation may be continuous (where blood is withdrawn and returned by separate needles) or intermittent (where blood is withdrawn and separated, then returned via the same needle).

Membrane fltration
Plasma is continuously filtered through a large pore filter (molecular weight cut-off typically 1,000,000D). Plasma is discarded and replaced by infusion of an equal volume of replacement fluid. The technique is similar to haemofiltration and uses the same equipment.

Replacement fluid
Most patients will tolerate replacement with a plasma substitute. Some fresh frozen plasma will be necessary after the exchange to replace coagulation factors. The only indication to replace plasma loss with all fresh frozen plasma is where plasma exchange is being performed to replace missing plasma factors.

Complications
• Circulatory instability                   Intravascular volume changes
              Removal of circulating catecholamines
              Hypocalcaemia
• Reduced intravascular COP            If replacement with crystalloid
• Infection                                     Reduced plasma opsonisation
• Bleeding                                      Removal of coagulation factors

Indications
Autoimmune disease
Goodpasture’s syndrome
Guillain–Barre syndrome
Myasthenia gravis
Pemphigus
Rapidly progressive glomerulonephritis
Systemic lupus erythematosus
Thrombotic thrombocytopaenic purpura
Immunoproliferative disease
Cryoglobulinaemia
Multiple myeloma
Waldenstrom’s macroglobulinaemia
Poisoning
Paraquat
Others
Meningococcaemia (possible benefit)
Sepsis (possible benefit)
Reye’s syndrome

0 comments:

Post a Comment